We are live on ! Find out more
CEI

Clark Estates Inc Portfolio holdings

AUM $434M
1-Year Est. Return 15%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+15%
3 Year Est. Return
+34.46%
5 Year Est. Return
+32.78%
10 Year Est. Return
+216.75%
AUM
$434M
AUM Growth
+$17.5M
Cap. Flow
-$3.16M
Cap. Flow %
-0.73%
Top 10 Hldgs %
52.76%
Holding
108
New
11
Increased
17
Reduced
16
Closed
18
Avg Time Held
10.2 quarters
Top 10 Avg Time Held
4.1 quarters
Top 20 Avg Time Held
5.7 quarters

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$25.8M
2
HSIC icon
Henry Schein
HSIC
+$9.71M
3
UL icon
Unilever
UL
+$3.76M
4
BBY icon
Best Buy
BBY
+$2.9M
5
SONY icon
Sony
SONY
+$2.81M

Top Sells

Rank Stock Value
1
ECML icon
Euclidean Fundamental Value ETF
ECML
+$15M
2
AVNS icon
Avanos Medical
AVNS
+$11.8M
3
IQV icon
IQVIA
IQV
+$7.5M
4
SOLV icon
Solventum
SOLV
+$6.56M
5
MDT icon
Medtronic
MDT
+$5.24M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Miscellaneous 21.8%
3 Technology 13.51%
4 Communication Services 11.78%
5 Consumer Staples 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GILD icon
26
Gilead Sciences
GILD
$183B
$3.29M 0.76%
26,022
– –
2019 Q3
27 quarters
ZD icon
27
Ziff Davis
ZD
$1.98B
$3.27M 0.75%
62,425
-7,275
-10% -$329K
2023 Q2
12 quarters
STRA icon
28
Strategic Education
STRA
$1.82B
$3.24M 0.75%
42,300
+14,700
+53% +$1.16M
2025 Q4
2 quarters
WEX icon
29
WEX
WEX
$5.95B
$3.08M 0.71%
21,800
+6,700
+44% +$993K
2023 Q1
13 quarters
TDC icon
30
Teradata
TDC
$2.83B
$3.04M 0.7%
87,600
-10,100
-10% -$307K
2024 Q3
7 quarters
WKC icon
31
World Kinect Corp
WKC
$1.86B
$3.02M 0.7%
91,600
– –
2025 Q4
2 quarters
HRMY icon
32
Harmony Biosciences
HRMY
$2.16B
$2.96M 0.68%
81,300
– –
2025 Q1
5 quarters
FTDR icon
33
Frontdoor
FTDR
$5.36B
$2.95M 0.68%
38,000
– –
2026 Q1
1 quarter
AOS icon
34
A.O. Smith
AOS
$7.87B
$2.89M 0.67%
+46,000
New +$2.79M
2026 Q2
0 quarters
DORM icon
35
Dorman Products
DORM
$3.66B
$2.87M 0.66%
21,000
– –
2026 Q1
1 quarter
MTCH icon
36
Match Group
MTCH
$9.72B
$2.85M 0.66%
74,800
– –
2024 Q1
9 quarters
INCY icon
37
Incyte
INCY
$22B
$2.83M 0.65%
25,000
– –
2024 Q2
8 quarters
EXPE icon
38
Expedia Group
EXPE
$32.8B
$2.81M 0.65%
11,000
-100
-0.9% -$23.8K
2026 Q1
1 quarter
ADUS icon
39
Addus HomeCare
ADUS
$2.14B
$2.81M 0.65%
+28,000
New +$2.64M
2026 Q2
0 quarters
VTRS icon
40
Viatris
VTRS
$19.8B
$2.72M 0.63%
171,566
– –
2020 Q4
22 quarters
GNTX icon
41
Gentex
GNTX
$4.4B
$2.65M 0.61%
+105,000
New +$2.48M
2026 Q2
0 quarters
TNET icon
42
TriNet
TNET
$3.06B
$2.6M 0.6%
+52,500
New +$2.25M
2026 Q2
0 quarters
CDW icon
43
CDW
CDW
$19B
$2.57M 0.59%
18,275
– –
2026 Q1
1 quarter
OSPN icon
44
OneSpan
OSPN
$671M
$2.54M 0.59%
177,000
– –
2025 Q3
3 quarters
BMY icon
45
Bristol-Myers Squibb
BMY
$116B
$2.48M 0.57%
43,000
– –
2021 Q1
21 quarters
OPCH icon
46
Option Care Health
OPCH
$4.66B
$2.47M 0.57%
+118,000
New +$2.74M
2026 Q2
0 quarters
MMS icon
47
Maximus
MMS
$3.04B
$2.46M 0.57%
45,700
+18,562
+68% +$1.16M
2025 Q1
5 quarters
KFY icon
48
Korn Ferry
KFY
$4.02B
$2.45M 0.56%
36,800
– –
2026 Q1
1 quarter
UPBD icon
49
Upbound Group
UPBD
$898M
$2.4M 0.55%
113,000
– –
2025 Q1
5 quarters
KBR icon
50
KBR
KBR
$4.46B
$2.39M 0.55%
69,200
+16,700
+32% +$582K
2025 Q4
2 quarters

Similar funds

Clark Estates Inc's Q2 2026 Portfolio in Review

As of Q2 2026, Clark Estates Inc held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Clark Estates Inc's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Miscellaneous and Technology.

  • Clark Estates Inc's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
  • Clark Estates Inc added most to Henry Schein in Q2 2026, an estimated $9.71M increase.
  • Clark Estates Inc's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
  • Clark Estates Inc fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
  • Clark Estates Inc's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
  • Clark Estates Inc opened 11 new positions and closed 18 in Q2 2026.
  • Clark Estates Inc's portfolio value rose 4.2% quarter-over-quarter to $434M.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.